Updated Jul 16, 2026
PERLROTH VICTOR is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Victor Perlroth is the Chairman and CEO of Kodiak Sciences Inc., a biopharmaceutical company focused on developing therapeutics for retinal diseases. He has been involved in the company since its early stages and has played a key role in its strategic direction.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-27 | KOD | Kodiak Sciences Inc. | M — Option exercise | 300.0K | $1.04 | $312K |
Victor Perlroth is the Chairman and CEO of Kodiak Sciences Inc., a biopharmaceutical company focused on developing therapeutics for retinal diseases. He has been involved in the company since its early stages and has played a key role in its strategic direction.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PERLROTH VICTOR profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.